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Abstract
Rhabdomyosarcoma is relatively seen in the pediatric age group with the head and neck region as the
commonest site. To the best of our knowledge, few cases of laryngeal involvement in adult have been
described in the literature. Biologically, rhabdomyosarcoma is different from squamous cell carcinoma,
which is the commonest tumor of the larynx. A previously healthy non-smoker 77-year-old lady
presented to the ENT outpatient with a six weeks history of intermittent alteration of voice quality. She
had no history of sore throat, or any symptoms suggesting laryngo-pharyngeal reflux. Examination
showed asymmetry of the left arytenoid cartilage and aryepiglottic fold. She subsequently had a direct
laryngoscopy and biopsy. Histology and immunohistochemistry examination suggested the diagnosis of
mesenchymal neoplasm. Following discussion at MDT she subsequently had a total laryngectomy.
Histology confirmed a completely excised laryngeal rhabdomyosarcoma. Rhabdomyosarcoma of larynx
in adult is a rare disease. Surgical treatment with or without adjuvant radiotherapy is currently the
treatment of choice for this disease.
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Résumé
Le Rhabdomyosarcome est relativement connu dans le groupe d’âge pédiatrique et les régions les plus
touchées sont la tête et le cou. A notre connaissance, peu de cas de l’implication du larynx chez des
adultes ont été cités dans la littérature. Biologiquement, rhabdomyosarcome est différent de la cellule
squameuse carcinome, qui est la tumeur de larynx la plus ordinaire. Une femme non-fumeuse, âgée de 77
ans d’une très bonne santé au départ, s’est présentée à l’ORL ambulatoire avec une période de six
semaines histoires de l’altération répétée de la qualité de la voix. Elle n’avait pas d’antécédente de maux
de gorge ou aucun symptômes suggestifs le reflux laryngo-pharyngien. L’examen a montré l’asymétrie
de la gauche aryténoïde cartilage aryepiglottique pli. Elle a par la suite eu une laryngoscopie directe et la
biopsie. L’examen histologique et immunohistochimie a suggéré le diagnostique des tumeurs
mesenchymteuses, néoplasme. A la suite d’une discussion au MDT elle a ensuite eu une laryngectomie
totale. L’histologie a confirmé une excisée larynx chez des adultes qui est une maladie rare. Le
traitement chirurgical avec ou sans radiothérapie adjuvante est actuellement le traitement du choix pour
cette maladie.
Mots clés: Rhabdomosarcome, le cancer du larynx
Introduction
Laryngeal cancer is an important cause of morbidity
and mortality accounting to 25% of all head and neck
cancers.1 The vast majority of laryngeal cancers are
squamous cell carcinoma. Rhabdomyosarcoma is a
malignant tumor of striated muscle rarely occurs in
the larynx. In adults, rhabdomyosarcomas are
extremely rare tumors, with few cases of these tumors
have been adequately described in world literature in
the adult population.2-4
There is very scanty literature on the
presentation and behavior of laryngeal
rhabdomyosarcoma. However because it is the most
common malignant mesenchymal tumor in children,5
pediatric literature indicates that the most common
site of presentation is in the head and neck region
(35%). Lungs, bone marrow, bones, liver and brain
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are among the most common sites of metastases.6
Five years survival ranges from 30% in
patients with metastasis at presentation to 80% in
those where the disease is localized and complete
resection is performed.4 It is unclear if
rhabdomyosarcoma in larynx behaves similarly to
those histologically different tumors occurring in
other sites. Biologically, rhabdomyosarcoma is quite
different from the more common cancer in larynx,
which is squamous cell carcinoma. The diagnostic
difficulties, immunohistochemistry and long term
outcome of the various treatment modalities for adult
primary laryngeal rhabdomyosarcoma are discussed.
Case report
A previously healthy non-smoker 77-year-old lady
presented to the ENT outpatient with a six weeks
history of intermittent alteration of voice quality. She
had no history of sore throat or feeling of lump in
throat, and had no symptoms suggesting laryngo-
pharyngeal reflux.
Initial examination with a flexible
laryngoscope showed asymmetry of the left arytenoid
cartilage and aryepiglottic fold. She subsequently had
a direct laryngoscopy were an irregular swelling of
the left arytenoid cartilage and left aryepiglottic fold
was found. The tumor extended into the region of
posterior comissure and adjacent cricoid cartilage.
However the piriform fossa, vocal cords, epiglottis,
valleculla, appeared normal. Biopsy was taken from
the left arytenoids and aryepiglottic fold.
CT scan of the larynx shows a bulky tumor
involving the left arytenoid and post-cricoid cartilage.
There was no nodal involvement and no evidence of
metastasis on chest scan.
Figure 1. The laryngeal specimen demonstrated a
well-circumscribed tumor measured 3.0 cm in
maximum diameter
The diagnosis of a mesenchymal neoplasm
was made and following discussion at
multidisciplinary team meeting (MDT), she
subsequently had a total laryngectomy. (Figures 1 and
2) On immunohistochemistry the cells, demonstrated
very bizarre staining for desmin and were strongly
positive for vimentin, myoglobin and MyoD1.
(Figures 3, 4 and 5) However they were negative for
cytokeratin, EMA, CEA, S-100 protein and
actin.There was no invasion of the underlying
cartilage and the tumor was completely excised with a
thin margin of about 0.5 mm. A diagnosis of
completely excised laryngeal pleomorphic
rhabdomyosarcoma was confirmed. She is been
regularly followed up at the MDT Clinic, and she had
no signs of local or regional recurrence over a year
follow up.
Figure 2. Shows homogenous greyish-yellow cut
surface. Sections confirmed the presence of a tumor
on posterior wall of the cricoid cartilage
Discussion
Rhabdomyosarcomas are mesenchymal tumors
usually seen in children.4 Though in children it is
reported to occur commonly in the head and neck
region, the larynx is a very rare site even in this
group.6 The literature on laryngeal
Rhabdomyosarcomas indicates that in the larynx the
tumor tends to originate in the vocal cord region and
appear as polypoid mass, which may extend above
and below the vocal cord.7
Presentation can vary from alteration in
voice to a feeling of strange lump sensation in throat,
or on rare occasions it may be life threatening because
of upper airway obstruction.7 It is important to note
that it’s presentation does not differ from the common
presentations of squamous cell carcinoma, however
they tend to grow rapidly and present with a short
history of onset of symptoms.8 The challenge is to
differentiate clinically benign from malignant lesions,
when they present as a polypoid tumor. 7It is not clear
if smoking plays any role in rhadomyosarcoma of the
larynx. Our patient was a non –smoker. To the best of
our knowledge, there is no association between
smoking and rhabdomyosarcoma. Diagnosis is made
from biopsy on direct laryngoscopy. CT scan is
important in determining the extent of tumor.
There are four main types of
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rhabdomyosarcoma. These are embryonal, alveolar,
pleomorphic and botryoid. It is important to note that
the pleomorphic type is uncommon in children and is
rare, even in adults.9
Figure 3. Demonstrates sheets of undifferentiated
round and spindle – shaped cells. Some of the cells
shows striking nuclear pleomorphism, with very
bizarre nuclear features. Many of the cells were
multinucleated with prominent eosinophilic
cytoplasm. In addition tadpole-shaped and strap –
shaped cells are present (H & E)
Figure 4. Showing myoglobin
Figure 5. Showing MyoD1
Cross-striations are usually visible with
ordinary hematoxylin-eosin staining accentuated by
phosphotungstic acid – hematoxylin (PTAH) staining.
Histologically tumor composed of sheets of anaplastic
cells, several of the cells shows striking nuclear
pleomorphism, with very bizarre nuclear features.
Many of the cells are multinucleated with prominent
eosinophilic cytoplasm. Tadpole-shaped and strap –
shaped cells are commonly present (Figure 4).9
It is important to note that
immunohistochemistry plays a key role in diagnosis.
The tumor cells are strongly positive for desmin,
vimentin, myoglobin and MyoD1, but negative for
cytokeratine, epithelia membrane antigen, CEA, S-
100 protein, and actin. MyoD1 RNA protein is highly
sensitive and specific for rhabdomyosarcoma. 10 -12
Electron microscopic examination may be useful
especially in uncertain cases.7
Treatment and prognosis is based on results
of the Intergroup Rhabdomyosarcoma study group
(IRS).13,14 Surgical treatment with adjuvant
radiotherapy is currently the treatment of choice for
laryngeal disease.2 However the use of adjuvant
combination Chemotherapy with radiotherapy is
gaining ground and reducing the need for mutilating
surgery in head and neck rhabdomyosarcoma15,16;
however it is not clear if this modality of treatment
has any significant effect on outcome in adult
laryngeal disease considering that only few cases has
been reported. Improvement in outcome has been
shown to occur with multimodality treatment
regimens for head and neck rhabdomyosarcoma.17
Conclusion
Rhabdomyosarcoma should be considered in any
patient with a laryngeal polypoidal lesion and
presenting with a very short history.
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